American Cancer Society

In our current era of rapidly developing cancer drugs and therapies, we also see improvement of cancer treatment outcomes stagnating when it comes to determining quality of life or long-term survival. This is because while new treatments are making small incremental progress in outcomes, most cancer patients still depend on conventional methods that are both toxic and ineffective. While new cancer drugs are becoming more precise or targeted, less attention is being paid to the overall health and wellbeing of the patient, which we propose is essential for long-term cancer control and improving a patient’s quality of life.

This latest offering from the Gale Group gives lay readers a comprehensive look at the current state of cancer and its therapies, covering specific cancer types, diagnostic procedures, side effects, drugs, and treatments. The two-volume set comprises over 450 signed entries, authored by an array of healthcare professionals, including physicians, nurses, pharmacists, and medical writers.